This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,910.28, is a delivery order for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and is a Firm Fixed Price arrangement.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award was not designated with any set-aside requirements, indicating open competition. As a major supplier of pharmaceutical and medical products to federal agencies, including the military and veterans' healthcare systems, AmerisourceBergen plays a critical role in ensuring the availability of essential medicines and medical supplies to meet the healthcare needs of government beneficiaries.
Generated 3/5/25, 9:55 AM